| Literature DB >> 33242159 |
Kathrine S Rallis1,2, Anna Wozniak3,4, Sara Hui3,4, Adam Stammer4, Cigdem Cinar5, Min Sun5, Taylor Fulton-Ward5, Alison A Clarke6, Savvas Papagrigoriadis7, Apostolos Papalois8, Michail Ch Sideris9.
Abstract
The mounting global cancer burden has generated an increasing demand for oncologists to join the workforce. Yet, students report limited oncology exposure in undergraduate medical curricula, while undergraduate oncology mentorships remain underutilised. We established an undergraduate oncology society-led mentorship programme aimed at medical students across several UK universities to increase medical student oncology exposure. We electronically recruited and paired oncologist mentors and medical student mentees and distributed a dedicated questionnaire (pre- and post-mentorship) to compare mentees' self-reported cancer specialty knowledge and oncology career motivation after undertaking a 6-week mentorship. We also determined students' interest across specialties and subspecialties and measured mentor availability via percentage programme uptake. Statistical analysis included univariate inferential tests on SPSS software. Twentynine (23.4%) of 124 oncology specialists agreed to become mentors. The mentorship was completed by 30 students across three medical schools: 16 (53.3%) Barts, 10 (33.3%) Birmingham, and 4 (13.3%) King's; 11 (36.7%) mentored by medical oncologists, 10 (33.3%) by clinical/radiation oncologists, and 9 (30%) by surgical oncologists. The mentorship generated a statically significant increase in students' knowledge of the multidisciplinary team and all oncology-related specialties including academia/research but not interest towards a career in oncology. Undergraduate oncology mentoring is an effective educational, networking and motivational tool for medical students. Student societies are a valuable asset in cultivating medical student oncology interest by connecting students to faculty and increasing mentor accessibility. Further research should focus on developing an optimal mentorship structure and evaluating long-term outcomes of such educational initiatives.Entities:
Keywords: Mentoring; Surveys and questionnaires; UK medical students; Undergraduate medical education; Undergraduate oncology society; Undergraduate oncology teaching
Mesh:
Year: 2020 PMID: 33242159 PMCID: PMC7688447 DOI: 10.1007/s13187-020-01919-7
Source DB: PubMed Journal: J Cancer Educ ISSN: 0885-8195 Impact factor: 1.771
Fig. 1Structured model for setting up a student mentorship programme through a student interest group outlining the process of mentor recruitment and the student allocation cycle
NHS Trust affiliation, specialty and subspecialty of all contacted (n = 124) and confirmed (n = 29) mentors
| Contacted Mentorsa | Confirmed Mentorsa | |
|---|---|---|
| NHS Foundation Trust | ||
| Barts Health | 36 (29.0) | 12 (41.4) |
| University Hospitals Birmingham | 49 (39.5) | 13 (44.8) |
| King’s College Hospital | 39 (31.5) | 4 (13.8) |
| Specialty | ||
| Medical Oncology | 56 (45.5) | 11 (37.9) |
| Clinical/Radiation Oncology | 29 (23.6) | 8 (27.6) |
| Surgical Oncology | 31 (24.4) | 10 (34.5) |
| Other* | 7 (5.7) | – |
| Subspecialtyb | ||
| Bone cancer | 1 (0.8) | – |
| Brain cancer | 5 (4.0) | 2 (6.9) |
| Breast cancer | 40 (32.3) | 7 (24.1) |
| Colorectal cancer | 13 (10.5) | 6 (20.7) |
| Gastrointestinal cancer | 21 (16.9) | 4 (13.8) |
| Germ cell tumours | 3 (2.4) | – |
| Gynaecological cancer | 15 (12.1) | 3 (10.4) |
| Haematological cancer | 7 (5.7) | 1 (3.5) |
| Head and neck cancer | 8 (6.5) | – |
| Hepatobiliary cancer | 8 (6.5) | 1 (3.5) |
| Lung cancer | 26 (21.0) | 6 (20.7) |
| Lymphoma | 11 (8.9) | 3 (10.4) |
| Melanoma | 4 (3.2) | 2 (6.9) |
| Neuroendrocine cancer | 5 (4.0) | 2 (6.9) |
| Neurological cancer | 4 (3.2) | – |
| Paediatric cancer | 2 (1.6) | 1 (3.5) |
| Sarcoma | 9 (7.3) | 5 (17.2) |
| Skin cancer | 9 (7.3) | 3 (10.4) |
| Teenager and young adult cancer | 2 (1.6) | – |
| Urological cancer | 31 (25.0) | 8 (27.6) |
aData given as number of mentors (%)
bOne or more subspecialties per mentor
*Other specialties included cardiology (n = 1), haematology (n = 3), palliative medicine (n = 2) and pneumonology (n = 1) cancer specialists
University affiliation, year of study and gender of all applicants (n = 79) and mentees who completed the mentorship (n = 30)
| Total applicantsa | Menteesa | |
|---|---|---|
| University | ||
| Barts and the London | 50 (63.3) | 16 (53.3) |
| Birmingham University | 14 (17.7) | 10 (33.3) |
| King’s College London | 15 (19.0) | 4 (13.3) |
| Year of study | ||
| Year 1 | 28 (35.4) | 7 (23.3) |
| Year 2 | 21 (26.6) | 8 (26.7) |
| Year 3 | 19 (24.1) | 10 (33.3) |
| Year 4 | 7 (8.9) | 4 (13.3) |
| Intercalating | 4 (5.1) | 1 (3.3) |
| Gender | ||
| Male | 24 (30.4) | 10 (33.3) |
| Female | 55 (69.6) | 20 (66.7) |
aData given as number of students (%)
Declared specialty and field of interest of all applicants (n = 79) and mentees who completed the mentorship (n = 30)
| Total applicantsa | Menteesa | |
|---|---|---|
| Specialty of interestb | ||
| Medical oncology | 62 (78.5) | 25 (83.3) |
| Clinical/radiation oncology | 45 (57.0) | 18 (60.0) |
| Surgical oncology | 51 (64.6) | 16 (53.3) |
| Academia/research in oncology | 54 (68.4) | 24 (80.0) |
| Field of interestb | ||
| Breast cancers | 52 (65.8) | 17 (56.7) |
| Gastrointestinal cancers | 56 (70.9) | 22 (73.3) |
| Gynaecological cancers | 43 (54.4) | 14 (46.7) |
| Haematological cancers | 64 (81.0) | 23 (76.7) |
| Head and neck cancers | 44 (55.7) | 14 (46.7) |
| Lung cancers | 57 (72.2) | 22 (73.3) |
| Urological cancers | 34 (43.0) | 15 (50.0) |
aData given as number of students (%)
bOne or more selected by students
Comparison of mentees’ responses from pre- and post-mentorship questionnaires (n = 30)
| Question | Pre-mentorshipa | Post-mentorshipa | |
|---|---|---|---|
| Rate your interest in oncology | 4.7 ± 0.5 | 4.7 ± 0.5 | 0.738 |
| Rate your knowledge of the following: | |||
| Members of the multidisciplinary team in oncology services | 3.2 ± 0.6 | 4.0 ± 0.8 | < 0.001* |
| The role of medical oncologists | 3.1 ± 0.8 | 4.0 ± 0.8 | < 0.001* |
| The role of surgical oncologists | 2.8 ± 0.9 | 3.4 ± 1.1 | 0.006 |
| The role of clinical oncologists | 2.9 ± 0.7 | 3.8 ± 1.1 | < 0.001 |
| The involvement of oncologists in academia/research | 3.2 ± 0.8 | 4.0 ± 0.8 | 0.001* |
aData is reported as the mean value of the Likert score ± standard deviation
bp value obtained from WSR test analysis between pre- and post-mentorship questionnaires
*Inneffective pairing as determined by Spearman correlation coefficient (one-tailed); p value confirmed on MWU test analysis between pre- and post-mentorship questionnaires
Mentees’ free text responses to qualitative feedback in post-mentorship questionnaire (n = 30)
| Question | Menteesa |
|---|---|
| What is the most important thing you gained from this programme?b | |
| Clinical experience | 10 (33.3) |
| Communication skills | 9 (30.0) |
| Learn about cancer patient management | 5 (16.7) |
| Connect with mentors | 4 (13.3) |
| Familiarise with breaking bad news | 4 (13.3) |
| Insight into multidisciplinary team | 4 (13.3) |
| Insight into research (including clinical trials) | 4 (13.3) |
| Inspired and motivated | 3 (10.0) |
| Observe doctor-patient relationship | 3 (10.0) |
| Research opportunity | 3 (10.0) |
| Academic, research or career advice | 3 (10.0) |
| Insight into oncologists’ work | 2 (6.7) |
| Confirm career aspiration | 1 (3.3) |
| Consolidate textbook learning | 1 (3.3) |
aData given as number of students (%)
bOne or more responses per student